Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 990 | 489 | 86 | 11 | 41 |
| Receivables | 2 | N/A | N/A | N/A | 0 |
| Inventories | 24 | 26 | 17 | 14 | 16 |
| Other current assets | 8 | 8 | 8 | 8 | 8 |
| TOTAL | $1,026 | $528 | $112 | $34 | $66 |
| Non-Current Assets | |||||
| PPE Net | 20 | 23 | 26 | 30 | 33 |
| TOTAL | $20 | $23 | $26 | $30 | $33 |
| Total Assets | $1,046 | $551 | $139 | $64 | $98 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 63 | 58 | 90 | 98 | 97 |
| Accrued Expenses | 24 | 32 | 29 | 33 | 21 |
| TOTAL | $1,051 | $748 | $686 | $772 | $834 |
| Non-Current Liabilities | |||||
| Long Term Debt | 949 | 358 | 63 | N/A | N/A |
| TOTAL | $949 | $358 | $63 | $N/A | $N/A |
| Total Liabilities | $2,000 | $1,105 | $749 | $772 | $834 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 166 | 100 | 56 | 35 |
| Common Shares | 2 | 304 | 192 | 60 | 35 |
| Retained earnings | -20,219 | -19,135 | -18,167 | -17,529 | -17,435 |
| Other shareholders' equity | -3 | -4 | -3 | -4 | -3 |
| TOTAL | $-955 | $-555 | $-611 | $-709 | $-735 |
| Total Liabilities And Equity | $1,046 | $551 | $139 | $64 | $98 |